1. Home
  2. NRP vs LQDA Comparison

NRP vs LQDA Comparison

Compare NRP & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRP
  • LQDA
  • Stock Information
  • Founded
  • NRP 2002
  • LQDA 2004
  • Country
  • NRP United States
  • LQDA United States
  • Employees
  • NRP N/A
  • LQDA N/A
  • Industry
  • NRP Coal Mining
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRP Energy
  • LQDA Health Care
  • Exchange
  • NRP Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • NRP 1.4B
  • LQDA 1.3B
  • IPO Year
  • NRP N/A
  • LQDA 2018
  • Fundamental
  • Price
  • NRP $93.67
  • LQDA $12.94
  • Analyst Decision
  • NRP
  • LQDA Strong Buy
  • Analyst Count
  • NRP 0
  • LQDA 7
  • Target Price
  • NRP N/A
  • LQDA $28.33
  • AVG Volume (30 Days)
  • NRP 15.6K
  • LQDA 880.9K
  • Earning Date
  • NRP 05-06-2025
  • LQDA 05-12-2025
  • Dividend Yield
  • NRP 4.15%
  • LQDA N/A
  • EPS Growth
  • NRP N/A
  • LQDA N/A
  • EPS
  • NRP 11.35
  • LQDA N/A
  • Revenue
  • NRP $245,027,000.00
  • LQDA $13,996,000.00
  • Revenue This Year
  • NRP N/A
  • LQDA $218.03
  • Revenue Next Year
  • NRP N/A
  • LQDA $243.03
  • P/E Ratio
  • NRP $9.22
  • LQDA N/A
  • Revenue Growth
  • NRP N/A
  • LQDA N/A
  • 52 Week Low
  • NRP $81.74
  • LQDA $8.26
  • 52 Week High
  • NRP $113.04
  • LQDA $16.81
  • Technical
  • Relative Strength Index (RSI)
  • NRP 32.91
  • LQDA 36.75
  • Support Level
  • NRP $105.00
  • LQDA $14.41
  • Resistance Level
  • NRP $106.23
  • LQDA $15.09
  • Average True Range (ATR)
  • NRP 3.00
  • LQDA 0.65
  • MACD
  • NRP -1.26
  • LQDA -0.14
  • Stochastic Oscillator
  • NRP 5.56
  • LQDA 2.65

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. The business activity of the group functions through the United States.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: